Stocktwits on MSN
Webull stock tumbles to all-time low — why is retail still bullish?
BULL stock has lost about 91% of its value from its 52-week high of $79.56. ・On Jan. 27, Webull announced that it has ...
Stocktwits on MSN
Webull stock has fallen more than 50% in last 6 months, it's again down today – why are traders mixed on it?
Last month, Webull announced that it has launched ‘zero-commission’ sports prediction markets through its partnership with Kalshi, for major sporting events. ・Webull completed its merger with SK ...
Webull Corporation (NASDAQ:BULL) shares are trading higher Thursday after the company announced it will reintroduce crypto trading to its global customer base and integrate Webull Pay back into Webull ...
Webull Corp (NASDAQ:BULL) shares are trading lower by 7.37% to $12.51 during Friday’s session, reacting to the release of the company’s first-quarter financial results late Thursday. What To Know: The ...
Rosenblatt Securities has issued a buy rating on Webull (NASDAQ: BULL), arguing that its 28% drop over the last three months presents a buying opportunity before the company reports its Q4 earnings.
In late January 2026, Webull Financial LLC highlighted its expanding partnership with CFTC-regulated Kalshi, offering users sports and Big Game prediction markets with $0 commission on select event ...
Alice Hoekstra is a former Content Strategist for Motley Fool Money, where she worked full-time for almost five years. Alice worked on content across a wide range of financial topics, including credit ...
Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will participate in the Corporate Connect Webinar Series hosted by Webull Financial being held virtually ...
Transfer RM10,000 or more in shares to receive 2% Match Rewards, with up to RM100,000 in Nvidia shares up for grabs! ...
These days you don’t have to pay a penny in commissions to trade stocks or ETFs or fork over a dime to access investment research and portfolio management tools. It’s the perks that’ll cost you extra.
Akari Therapeutics, Plc (Nasdaq: AKTX ), an oncology biotechnology company pioneering next-generation antibody drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results